Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples